DekaBank Deutsche Girozentrale lifted its stake in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) by 8.0% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 616,239 shares of the company's stock after buying an additional 45,693 shares during the quarter. DekaBank Deutsche Girozentrale owned about 0.26% of Cardinal Health worth $83,445,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other hedge funds and other institutional investors also recently modified their holdings of the stock. Cyrus J. Lawrence LLC bought a new position in shares of Cardinal Health in the fourth quarter worth approximately $26,000. Bellwether Advisors LLC bought a new position in shares of Cardinal Health in the fourth quarter worth approximately $32,000. Tompkins Financial Corp lifted its position in Cardinal Health by 106.7% during the first quarter. Tompkins Financial Corp now owns 248 shares of the company's stock valued at $34,000 after purchasing an additional 128 shares during the period. Lee Danner & Bass Inc. bought a new position in Cardinal Health during the fourth quarter valued at approximately $35,000. Finally, Itau Unibanco Holding S.A. bought a new position in Cardinal Health during the fourth quarter valued at approximately $36,000. Hedge funds and other institutional investors own 87.17% of the company's stock.
Wall Street Analysts Forecast Growth
CAH has been the topic of a number of research analyst reports. Mizuho increased their price objective on shares of Cardinal Health from $142.00 to $150.00 and gave the company an "outperform" rating in a research report on Monday, March 31st. Evercore ISI restated an "outperform" rating and set a $180.00 price objective (up previously from $175.00) on shares of Cardinal Health in a research report on Thursday, June 12th. UBS Group upped their target price on shares of Cardinal Health from $150.00 to $160.00 and gave the company a "buy" rating in a report on Tuesday, April 29th. Bank of America upped their target price on shares of Cardinal Health from $165.00 to $170.00 and gave the company a "buy" rating in a report on Tuesday, June 10th. Finally, Robert W. Baird upped their target price on shares of Cardinal Health from $156.00 to $170.00 and gave the company an "outperform" rating in a report on Friday, May 2nd. Three research analysts have rated the stock with a hold rating, eleven have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average price target of $157.43.
View Our Latest Stock Analysis on CAH
Cardinal Health Price Performance
Shares of CAH traded down $1.30 during mid-day trading on Friday, reaching $160.87. The stock had a trading volume of 1,314,182 shares, compared to its average volume of 2,241,478. Cardinal Health, Inc. has a 52-week low of $93.17 and a 52-week high of $168.44. The business's fifty day moving average is $157.67 and its 200 day moving average is $138.89. The firm has a market cap of $38.40 billion, a price-to-earnings ratio of 25.10, a P/E/G ratio of 1.59 and a beta of 0.68.
Cardinal Health (NYSE:CAH - Get Free Report) last announced its quarterly earnings data on Thursday, May 1st. The company reported $2.35 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.15 by $0.20. Cardinal Health had a net margin of 0.70% and a negative return on equity of 68.84%. The firm had revenue of $54.88 billion during the quarter, compared to analyst estimates of $55.33 billion. During the same quarter in the prior year, the firm posted $2.08 earnings per share. Cardinal Health's quarterly revenue was up .0% on a year-over-year basis. As a group, sell-side analysts anticipate that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.
Cardinal Health Increases Dividend
The business also recently announced a quarterly dividend, which will be paid on Tuesday, July 15th. Shareholders of record on Tuesday, July 1st will be given a $0.5107 dividend. The ex-dividend date of this dividend is Tuesday, July 1st. This represents a $2.04 dividend on an annualized basis and a yield of 1.27%. This is a boost from Cardinal Health's previous quarterly dividend of $0.51. Cardinal Health's dividend payout ratio is presently 31.83%.
Cardinal Health Profile
(
Free Report)
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
Read More

Before you consider Cardinal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardinal Health wasn't on the list.
While Cardinal Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.